Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells

Gething, 2012, A long neglected world malaria map: Plasmodium vivax endemicity in 2010, PLoS Negl Trop Dis, 6, e1814, 10.1371/journal.pntd.0001814 Price, 2007, Vivax malaria: neglected and not benign, Am J Trop Med Hyg, 77, 79, 10.4269/ajtmh.2007.77.79 Baird, 2013, Evidence and implications of mortality associated with acute Plasmodium vivax malaria, Clin Microbiol Rev, 26, 36, 10.1128/CMR.00074-12 Anstey, 2012, Plasmodium vivax: risk factors and pathogenesis, Adv Parasitol, 80, 151, 10.1016/B978-0-12-397900-1.00003-7 von Seidlein, 2013, Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report, Malar J, 12, 112, 10.1186/1475-2875-12-112 White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar J, 10, 297, 10.1186/1475-2875-10-297 Eyles, 1948, The parasitological pattern of relapsing Plasmodium vivax in military patients, J Natl Malar Soc, 7, 23 Pukrittayakamee, 2000, Therapeutic responses to different antimalarial drugs in vivax malaria, Antimicrob Agents Chemother, 44, 1680, 10.1128/AAC.44.6.1680-1685.2000 Sutanto, 2013, Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia, Antimicrob Agents Chemother, 57, 1128, 10.1128/AAC.01879-12 Douglas, 2011, Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics, Clin Infect Dis, 52, 612, 10.1093/cid/ciq249 Baird, 2002, Seasonal malaria attack rates in infants and young children in northern Ghana, Am J Trop Med Hyg, 66, 280, 10.4269/ajtmh.2002.66.280 Baird, 2012, Diagnosis and treatment of Plasmodium vivax malaria, Adv Parasitol, 80, 203, 10.1016/B978-0-12-397900-1.00004-9 Beutler, 1954, The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes, J Lab Clin Med, 44, 177 Beutler, 2007, Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development, Am J Trop Med Hyg, 77, 779, 10.4269/ajtmh.2007.77.779 Clark, 2009, Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility, Eur J Hum Genet, 17, 1080, 10.1038/ejhg.2009.8 Howes, 2012, G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map, PLoS Med, 9, e1001339, 10.1371/journal.pmed.1001339 Beutler, 2008, Glucose-6-phosphate dehydrogenase: a historical perspective, Blood, 111, 16, 10.1182/blood-2007-04-077412 Beutler, 1966, A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency, Blood, 28, 553, 10.1182/blood.V28.4.553.553 Boulard, 1972, The effect of copper ion on red cell enzyme activities, J Clin Invest, 51, 459, 10.1172/JCI106833 Beutler, 1994, G6PD deficiency, Blood, 84, 3613, 10.1182/blood.V84.11.3613.bloodjournal84113613 Filosa, 1996, Somatic cell selection is a major determinant of the blood cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency, Am J Hum Genet, 59, 887 Kim, 2011, Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening, PLoS One, 6, e28357, 10.1371/journal.pone.0028357 da Silva, 2008, Methods for equivalence and noninferiority testing, Biol Blood Marrow Transplant, 15, 120 Wolf, 1987, Detection of glucose-6-phosphate dehydrogenase deficiency in erythrocytes: a spectrophotometric assay and fluorescent spot test compared with a cytochemical method, Clin Chim Acta, 168, 129, 10.1016/0009-8981(87)90281-6 Wong, 2009, Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay, and molecular method for prediction of severe neonatal hyperbilirubinemia, Singapore Med J, 50, 62 Clyde, 1981, Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug, Bull World Health Organ, 59, 391 Salvidio, 1967, Nature of hemolytic crises and the fate of G6PD deficient, drug-damaged erythrocytes in Sardinians, N Engl J Med, 276, 1339, 10.1056/NEJM196706152762402 Pannacciulli, 1965, The course of experimentally induced hemolytic anemia in a primaquine-sensitive Caucasian: a case study, Blood, 25, 92, 10.1182/blood.V25.1.92.92 George, 1967, Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G6PD deficient subjects, J Lab Clin Med, 70, 80 Alving, 1960, Mitigation of the haemolytic effect of primaquine and enhancement of its against the exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: a preliminary report, Bull World Health Organ, 22, 621 Peters, 2009, Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women, J Histochem Cytochem, 57, 1003, 10.1369/jhc.2009.953828 Howes, 2013, Spatial distribution of G6PD deficiency variants across malaria-endemic regions, Malar J, 12, 418, 10.1186/1475-2875-12-418 Loucharoen, 2009, Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians, Science, 326, 1546, 10.1126/science.1178849 Baird, 2004, Primaquine therapy for malaria, Clin Infect Dis, 39, 1336, 10.1086/424663 John, 2012, Primaquine radical cure of Plasmodium vivax: a critical review of the literature, Malar J, 11, 280, 10.1186/1475-2875-11-280 Durand, 2014, Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax in the Amazon Basin of Peru, Am J Trop Med Hyg, 91, 18, 10.4269/ajtmh.13-0053 2010, 194 Rijken, 2012, Malaria in pregnancy in the Asia-Pacific region, Lancet Infect Dis, 12, 75, 10.1016/S1473-3099(11)70315-2 McGready, 2012, Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment regimens in early pregnancy: a population-based study, Lancet Infect Dis, 12, 388, 10.1016/S1473-3099(11)70339-5 Bennett, 2013, Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria, N Engl J Med, 369, 1381, 10.1056/NEJMc1301936